Cabaluna, Jeric .

HRN: 29-48-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
CEFTRIAXONE 1G (VIAL)
08/13/2026
08/20/2026
IV
1.125gms
Q12h
Soft Tissue Infection; Tc Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: